ERYTHROMYCIN 333 mg/1 (Erythromycin TABLET, DELAYED RELEASE) 333 mg/1

ERYTHROMYCIN 333 mg delayed-release tablets are an oral antibiotic used to treat bacterial infections. This medication is designed to release the active ingredient gradually for sustained effects.

Strength

333 mg/1

Pack Size

500 TABLET, DELAYED RELEASE in 1 BOTTLE (13668-587-05)

Manufacturer / TM Owner

Torrent Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ERYTHROMYCIN 333 mg delayed-release tablets are commonly used to treat various bacterial infections, including respiratory tract infections, skin infections, and certain sexually transmitted diseases. This antibiotic works by stopping the growth of bacteria, helping the body's immune system fight off the infection. It is often prescribed for conditions where prolonged antibiotic action is beneficial.

Side Effects

Common effects of ERYTHROMYCIN 333 mg delayed-release tablets may include gastrointestinal discomfort, such as nausea, vomiting, or diarrhea. Some users may also experience mild stomach pain or loss of appetite. These effects are generally temporary and should subside as the body adjusts to the medication.

Precautions & Warnings

ERYTHROMYCIN 333 mg delayed-release tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight and out of reach of children. Always follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication.

Avoid Interactions

ERYTHROMYCIN 333 mg delayed-release tablets may interact with other medications, including certain antibiotics, antifungals, and some heart medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while taking this medication.

Frequently Asked Questions

ERYTHROMYCIN 333 mg delayed-release tablets are used to treat bacterial infections, including respiratory tract infections, skin infections, and certain sexually transmitted diseases.

ERYTHROMYCIN 333 mg delayed-release tablets should be taken orally with a full glass of water, preferably on an empty stomach unless directed otherwise by a healthcare provider.

Common side effects may include gastrointestinal discomfort, nausea, vomiting, diarrhea, and mild stomach pain.

It is generally advised to avoid alcohol while taking ERYTHROMYCIN 333 mg delayed-release tablets to prevent potential interactions and side effects.

Store ERYTHROMYCIN 333 mg delayed-release tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.